TAK-280

TAK-280 · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-280, covering 2025-08-29 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Results: First-in-Human Study of TAK-280 in Participants With Solid Tumors [Phase 1, Phase 2]